Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
04-06 September, 2025
Not Confirmed
Not Confirmed
08-11 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
04-06 September, 2025
Industry Trade Show
Not Confirmed
08-11 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-approvals-drop-24-in-h1-2025-gsk-s-uti-med-vertex-s-non-opioid-painkiller-lead-pack-of-first-in-class-meds
28 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250528758830/en/Resolve-Therapeutics-and-Duke-Medical-School-Initiate-Observational-Study-of-Cell-free-RNA-in-Polytrauma-Patients
13 May 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/resolve-therapeutics-publishes-results-of-rslv-132-phase-2-long-covid-study-302143453.html
09 Nov 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/resolve-therapeutics-completes-enrollment-of-phase-2-long-covid-clinical-trial-301671085.html
19 Apr 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/04/19/2424527/0/en/Progyny-and-RESOLVE-to-Launch-National-Infertility-Awareness-Week-by-Ringing-the-Nasdaq-Stock-Market-Opening-Bell-and-Lighting-the-Empire-State-Building.html
24 Jun 2021
// CLINICAL TRAILS ARENA
https://www.clinicaltrialsarena.com/news/resolve-therapeutics-to-start-phase-ii-trial-of-rslv-132-for-long-covid/
23 Jun 2021
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/resolve-therapeutics-receives-fda-approval-to-initiate-phase-2-clinical-trial-of-rslv-132-in-long-covid-patients-301318002.html
ABOUT THIS PAGE